128 related articles for article (PubMed ID: 17690908)
1. Possible prognostic role of IL-17R in osteosarcoma.
Honorati MC; Cattini L; Facchini A
J Cancer Res Clin Oncol; 2007 Dec; 133(12):1017-21. PubMed ID: 17690908
[TBL] [Abstract][Full Text] [Related]
2. IL-17A/IL-17RA interaction promoted metastasis of osteosarcoma cells.
Wang M; Wang L; Ren T; Xu L; Wen Z
Cancer Biol Ther; 2013 Feb; 14(2):155-63. PubMed ID: 23192273
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 induces vascular endothelial growth factor expression and promotes angiogenesis through apoptosis signal-regulating kinase 1 in human osteosarcoma.
Tzeng HE; Tsai CH; Chang ZL; Su CM; Wang SW; Hwang WL; Tang CH
Biochem Pharmacol; 2013 Feb; 85(4):531-40. PubMed ID: 23219526
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma.
Su Y; Wagner ER; Luo Q; Huang J; Chen L; He BC; Zuo GW; Shi Q; Zhang BQ; Zhu G; Bi Y; Luo J; Luo X; Kim SH; Shen J; Rastegar F; Huang E; Gao Y; Gao JL; Yang K; Wietholt C; Li M; Qin J; Haydon RC; He TC; Luu HH
Oncogene; 2011 Sep; 30(37):3907-17. PubMed ID: 21460855
[TBL] [Abstract][Full Text] [Related]
5. XB130 expression in human osteosarcoma: a clinical and experimental study.
Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W
Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762
[TBL] [Abstract][Full Text] [Related]
6. Possible contribution of aminopeptidase N (APN/CD13) to invasive potential enhanced by interleukin-6 and soluble interleukin-6 receptor in human osteosarcoma cell lines.
Kido A; Krueger S; Haeckel C; Roessner A
Clin Exp Metastasis; 1999; 17(10):857-63. PubMed ID: 11089884
[TBL] [Abstract][Full Text] [Related]
7. Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas.
Park HR; Min K; Kim HS; Jung WW; Park YK
Pathol Res Pract; 2008; 204(8):575-82. PubMed ID: 18440723
[TBL] [Abstract][Full Text] [Related]
8. CUL4A expression in pediatric osteosarcoma tissues and its effect on cell growth in osteosarcoma cells.
Li X; Xu R; Liu H; Fang K
Tumour Biol; 2016 Jun; 37(6):8139-44. PubMed ID: 26715273
[TBL] [Abstract][Full Text] [Related]
9. Effects of vascular endothelial growth factor expression on pathological characteristics and prognosis of osteosarcoma.
Han G; Wang Y; Bi W; Jia J; Wang W; Xu M
Clin Exp Med; 2016 Nov; 16(4):577-584. PubMed ID: 26319790
[TBL] [Abstract][Full Text] [Related]
10. IL-17 enhances the susceptibility of U-2 OS osteosarcoma cells to NK cell lysis.
Honorati MC; Neri S; Cattini L; Facchini A
Clin Exp Immunol; 2003 Sep; 133(3):344-9. PubMed ID: 12930359
[TBL] [Abstract][Full Text] [Related]
11. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases participate in osteosarcoma invasion.
Bjørnland K; Flatmark K; Pettersen S; Aaasen AO; Fodstad O; Maelandsmo GM
J Surg Res; 2005 Aug; 127(2):151-6. PubMed ID: 16083752
[TBL] [Abstract][Full Text] [Related]
13. A humanized bone microenvironment uncovers HIF2 alpha as a latent marker for osteosarcoma.
Wagner F; Holzapfel BM; Martine LC; McGovern J; Lahr CA; Boxberg M; Prodinger PM; Grässel S; Loessner D; Hutmacher DW
Acta Biomater; 2019 Apr; 89():372-381. PubMed ID: 30836200
[TBL] [Abstract][Full Text] [Related]
14. Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem Cells.
Di Fiore R; Drago-Ferrante R; Pentimalli F; Di Marzo D; Forte IM; Carlisi D; De Blasio A; Tesoriere G; Giordano A; Vento R
J Cell Physiol; 2016 Aug; 231(8):1832-41. PubMed ID: 26679758
[TBL] [Abstract][Full Text] [Related]
15. NKD2, a negative regulator of Wnt signaling, suppresses tumor growth and metastasis in osteosarcoma.
Zhao S; Kurenbekova L; Gao Y; Roos A; Creighton CJ; Rao P; Hicks J; Man TK; Lau C; Brown AM; Jones SN; Lazar AJ; Ingram D; Lev D; Donehower LA; Yustein JT
Oncogene; 2015 Sep; 34(39):5069-79. PubMed ID: 25579177
[TBL] [Abstract][Full Text] [Related]
16. High Expression of XRCC6 Promotes Human Osteosarcoma Cell Proliferation through the β-Catenin/Wnt Signaling Pathway and Is Associated with Poor Prognosis.
Zhu B; Cheng D; Li S; Zhou S; Yang Q
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27455247
[TBL] [Abstract][Full Text] [Related]
17. TSSC3 overexpression reduces stemness and induces apoptosis of osteosarcoma tumor-initiating cells.
Huang Y; Dai H; Guo QN
Apoptosis; 2012 Aug; 17(8):749-61. PubMed ID: 22610481
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-17 receptor expression on vascular endothelial cells of masses of skeletal extramedullary disease in myeloma patients.
Yang JZ; Li Y; Sun LX; Fang J; Kong LJ; Zhang JQ
Pathol Res Pract; 2014 Sep; 210(9):586-90. PubMed ID: 24916639
[TBL] [Abstract][Full Text] [Related]
19. Combined administration of EGCG and IL-1 receptor antagonist efficiently downregulates IL-1-induced tumorigenic factors in U-2 OS human osteosarcoma cells.
Hönicke AS; Ender SA; Radons J
Int J Oncol; 2012 Aug; 41(2):753-8. PubMed ID: 22641358
[TBL] [Abstract][Full Text] [Related]
20. Expression of bone morphogenetic proteins by osteoinductive and non-osteoinductive human osteosarcoma cells.
Raval P; Hsu HH; Schneider DJ; Sarras MP; Masuhara K; Bonewald LF; Anderson HC
J Dent Res; 1996 Jul; 75(7):1518-23. PubMed ID: 8876605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
